|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.39 AUD | +4.00% |
|
-1.27% | -4.88% |
| Apr. 15 | Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3% | MT |
| Apr. 09 | Orthocell Revenue Soars 19% to AU$1.61 Million in Q1 | MT |
Orthocell Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was AUD 0.846859 million compared to AUD 0.764094 million a year ago. Net loss was AUD 4.06 million compared to AUD 4.65 million a year ago.
Basic loss per share from continuing operations was AUD 0.021 compared to AUD 0.024 a year ago. Diluted loss per share from continuing operations was AUD 0.021 compared to AUD 0.024 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.88% | 51.83M | |
| +5.66% | 109B | |
| +11.23% | 105B | |
| -0.38% | 22.25B | |
| -12.15% | 22.09B | |
| -7.66% | 18.68B | |
| -36.52% | 17.58B | |
| -10.09% | 16.85B | |
| +3.33% | 13.76B | |
| +36.58% | 12.46B |
ORTHOCELL LIMITED 
